NCT06890871View on ClinicalTrials.gov

Radiotherapy with Immunotherapy and Anti-Angiogenic Therapy for Advanced HER2-Negative Breast Cancer: a Single-Arm Study

PHASE1/PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 8, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Breast Cancer, Metastatic Breast Cancer
Interventions
RADIATION

Intensity-modulated radiotherapy

Radiotherapy With Immunotherapy and Anti-Angiogenic Therapy

DRUG

Immunotherapy Therapy

Radiotherapy With Immunotherapy and Anti-Angiogenic Therapy

Trial Locations (1)

430071

#169, Donghu Road, Wuchang District, Wuhan, Wuhan

All Listed Sponsors
lead

Zhongnan Hospital

OTHER